Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B

Creative Commons License

Papatheodoridis G., Dalekos G. N., İDİLMAN R., Sypsa V., Van Boemmel F., Buti M., ...Daha Fazla

JHEP REPORTS, cilt.3, sa.3, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 3 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.jhepr.2021.100290
  • Dergi Adı: JHEP REPORTS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Cirrhosis, Entecavir, Tenofovir, Prediction, RECEIVING ENTECAVIR, SCORING SYSTEM, THERAPY
  • Ankara Üniversitesi Adresli: Evet

Özet

Background & Aims: Recently, several risk scores for prediction of hepatocellular carcinoma (HCC) were developed in cohorts of treated Asian patients with chronic hepatitis B (CHB), but they have not been assessed in non-Asian patients. We evaluated the predictability and comparative utility of our PAGE-B and recent Asian HCC risk scores in nucleos(t)ide analogue (NA)-treated adult Caucasian patients with CHB, with or without well-documented compensated cirrhosis but not previous diagnosis of HCC.